GSK Consumer Health Recalls Five Excedrin Brands Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

This recall was issued December 23, 2020.

Company: Gsk Consumer Healthcare, Of Warren, N.J.
Posted: December 23, 2020
Recall Number: 21057
Quantity: About 433,600
Official Source: View on CPSC website ↗

Reason for Recall

Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).

Action Taken

Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine if there is a hole. If there is a hole in the bottle, contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. Bottles without a hole can be retained and used as directed.

Product Images

Recalled Excedrin with hole in the bottom of the bottle

Recalled Excedrin Migraine Caplets (50, 80, 100, 125, 200, 250 and 300-count)

Recalled Excedrin Migraine Geltabs (50, 80, 100, 125, 200, 250 and 300-count)

Recalled Excedrin Extra Strength Caplets (50, 80, 100, 125, 200, 250 and 300-count)

Recalled Excedrin PM Headache Caplets (50, 80, 100, 125, 200, 250 and 300-count)

Recalled Excedrin Tension Headache Caplets (50, 80, 100, 125, 200, 250 and 300-count)